September 28, 2011 (San Diego, California) — Deep-brain stimulation (DBS) to the subthalamic nucleus or globus pallidus internus has different effects on gait and balance in patients with Parkinson's ...

DBS (SGX:D05) has introduced real-time online tracking of cross-border collections for companies in India through a partnership with SWIFT Global Payments Innovation (gpi). DBS is reportedly first ...

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and the globus pallidus pars interna (GPi) has been shown to be an effective treatment for patients with Parkinson's disease. Strong ...

Medicare covers specific types of deep brain stimulation (DBS), such as thalamic VIM DBS for essential tremor and Parkinson’s tremor, as well as STN and GPi DBS for Parkinson’s disease. To be eligible ...

In comparing the efficacy of deep brain stimulation of the subthalmic nucleus and globus pallidus, both approaches were similarly effective in improving motor function in people with Parkinson disease ...

In a major study, investigators have compared how individuals with Parkinson's disease respond to deep brain stimulation (DBS) at two different sites in the brain. Contrary to current belief, patients ...

Researchers from University South Alabama College of Medicine, USA and National Institute for Physiological Sciences, Japan developed a new method of deep brain stimulation driven by motor cortical ...

The FDA has approved an expanded indication for the Infinity™ Deep Brain Stimulation (DBS) system (Abbott) to include targeting the internal globus pallidus, which may lead to symptom improvement in ...

Abbott Laboratories has won breakthrough device designation for its deep brain stimulation (DBS) system to be investigated in the use of treatment-resistant depression (TRD). The Abbott Park, IL-based ...